Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss
BIO-LOSEIT-I
1 other identifier
interventional
200
1 country
1
Brief Summary
This is a substudy to a randomised trial investigating the effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis (NCT02905864). This substudy aims to investigate any changes in biomarkers associated with the initial 8-week weight loss intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2016
CompletedFirst Posted
Study publicly available on registry
October 13, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedApril 23, 2018
April 1, 2018
2.2 years
September 23, 2016
April 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in collagen II degradation fragment α-C2M
Blood sampling
Week -8 to 0
Secondary Outcomes (5)
Change in collagen II degradation fragment β-C2M
Week -8 to 0
Change in non-coding RNA type snoRNAs U38 and U48
Week -8 to 0
Change in miRNA-454
Week -8 to 0
Change in miRNA let-7e
Week -8 to 0
Change in Nesfatin-1
Week -8 to 0
Study Arms (1)
Intensive dietary intervention
EXPERIMENTALSupervised dietary weight loss program lasting 8 weeks
Interventions
Participants receive a hypo-caloric formula diet containing 800 to 1,000 kcal/day. The formula diet consists of ready-to-use meal bars and powders to mix with water to make shakes, soups, or porridge. The weight loss programme consists of an 8-week period with full meal replacement by a standard liquid energy intake protocol. To facilitate compliance with the programme, participants will be scheduled for weekly facility-based group sessions with 6-8 participants led by a dietician. The recommendations for daily nutrient intake will be met.
Eligibility Criteria
You may qualify if:
- Same as parent trial (NCT02905864)
You may not qualify if:
- Same as parent trial (NCT02905864)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Parker Institute
Frederiksberg, Capital Region, 2000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
September 23, 2016
First Posted
October 13, 2016
Study Start
November 1, 2016
Primary Completion
January 1, 2019
Study Completion
June 1, 2019
Last Updated
April 23, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share